Treatment
-
Forward Look
What’s Next? Winter 2020/2021Using deep learning to detect tumor mutations.
by Christina Bennett
-
Multiple Myeloma: Choosing Your PathNew therapies provide hope and options for people as they monitor and manage this incurable blood cancer.
by Tara Haelle
-
Physicians Underestimate Severity of Radiation Side EffectsBreast cancer patients' symptoms after radiation therapy may go underrecognized, especially if these patients are Black or younger in age.
by Marci A. Landsmann
-
Drug Dependence After Breast SurgeryA study indicates that some breast cancer patients who receive mastectomy and reconstruction may be at risk of persistent drug use following surgery.
by Marcus A. Banks
-
Cancer Centers Cope With COVID-19 SurgeDoctors at cancer centers in states with record COVID-19 hospitalization rates reflect on how lessons from early in the pandemic are helping them care for patients during the current surge.
by Ashley P. Taylor
-
Liquid Biopsies May Ease Enrollment in Clinical TrialsA study shows that a blood test for gastrointestinal tumor mutations gave results in a third of the time needed for solid tissue testing. Patients who received the blood test were more likely to enroll in clinical trials.
by Emma Yasinski
-
What Is Tumor Mutational Burden?The Food and Drug Administration approved an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type. But some medical oncologists say it's not clear the biomarker is valid across all cancer types.
by Anna Azvolinsky
-
Taking Drug Dosing Off AutopilotPatient advocates with metastatic breast cancer argue that dosing of treatments for their disease should be more personalized and take into account quality of life.
by Marcus A. Banks
-
More Choices to Treat Lung CancerAdvances in precision medicine and immunotherapy have led to better treatments for many patients with advanced lung cancer. But having a wider selection of therapies to choose from can make treatments more complex.
by Kendall K. Morgan
-
Forward Look
What’s Next? Fall 2020A therapeutic vaccine targeting advanced cervical cancer.
by Anna Azvolinsky
